McDermott Will & Emery and D’hoir Beaufre Assist DBV Technologies

Overview


Emmanuelle Trombe, Bertrand Delafaye, Noëmie Fort and Pierre Menegaux advised French biopharmaceutical company DBV Technologies on the largest secondary Nasdaq offering of the year, a public offering of new shares is in the form of American Depositary Shares (ADSs) in the United States for $ 281.5 million. The shares are also listed on Euronext Paris.